IRIS
SCIONTI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.658
AS - Asia 1.159
EU - Europa 894
SA - Sud America 177
Continente sconosciuto - Info sul continente non disponibili 137
AF - Africa 58
OC - Oceania 8
Totale 4.091
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.578
SG - Singapore 457
IT - Italia 450
CN - Cina 208
IN - India 131
BR - Brasile 130
GB - Regno Unito 105
DE - Germania 100
VN - Vietnam 89
FI - Finlandia 52
CA - Canada 47
HK - Hong Kong 47
BD - Bangladesh 43
SE - Svezia 34
NL - Olanda 32
PK - Pakistan 29
ID - Indonesia 27
JO - Giordania 24
MX - Messico 21
SA - Arabia Saudita 18
ES - Italia 17
FR - Francia 16
RU - Federazione Russa 16
ZA - Sudafrica 15
CZ - Repubblica Ceca 12
EG - Egitto 12
IQ - Iraq 12
CO - Colombia 11
TR - Turchia 11
UA - Ucraina 10
MY - Malesia 9
LT - Lituania 8
NG - Nigeria 8
PE - Perù 8
AE - Emirati Arabi Uniti 7
AR - Argentina 7
AU - Australia 7
IE - Irlanda 7
IR - Iran 7
KE - Kenya 7
PT - Portogallo 7
VE - Venezuela 7
ET - Etiopia 6
LB - Libano 6
RO - Romania 6
EC - Ecuador 5
MA - Marocco 5
AL - Albania 4
CY - Cipro 4
GT - Guatemala 4
JP - Giappone 4
PH - Filippine 4
BG - Bulgaria 3
CL - Cile 3
HN - Honduras 3
HR - Croazia 3
KR - Corea 3
PS - Palestinian Territory 3
PY - Paraguay 3
TH - Thailandia 3
UZ - Uzbekistan 3
AT - Austria 2
AZ - Azerbaigian 2
CH - Svizzera 2
EU - Europa 2
IL - Israele 2
KZ - Kazakistan 2
LK - Sri Lanka 2
PL - Polonia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BO - Bolivia 1
BY - Bielorussia 1
CD - Congo 1
CM - Camerun 1
EE - Estonia 1
GE - Georgia 1
HU - Ungheria 1
JM - Giamaica 1
MD - Moldavia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 3.957
Salva come PNG Salva come JPEG
Città #
San Jose 302
Singapore 212
Ashburn 174
Chandler 161
Dallas 89
Santa Clara 79
Munich 72
Bengaluru 57
Hefei 57
Chicago 56
London 51
Council Bluffs 49
Milan 45
Beijing 42
Ho Chi Minh City 40
Hong Kong 36
Turku 35
Lawrence 34
Princeton 34
Catanzaro 33
Los Angeles 29
New York 26
Boardman 19
Ottawa 19
Helsinki 17
Amman 16
Hanoi 16
Wilmington 15
Rome 14
São Paulo 14
Jeddah 13
Carbonia 12
San Nicola Manfredi 12
Naples 11
Atlanta 10
Chennai 10
Montreal 10
San Francisco 10
Spezzano della Sila 10
The Dalles 10
Bologna 9
Brooklyn 9
Madrid 9
Delhi 8
Irbid 8
Manchester 8
Olomouc 8
Palermo 8
Catania 7
Cosenza 7
Da Nang 7
Kaunas 7
Aversa 6
Bari 6
Des Moines 6
Ercolano 6
Frankfurt am Main 6
Hyderabad 6
Nairobi 6
Redmond 6
Seattle 6
Addis Ababa 5
Afragola 5
Ahmedabad 5
Buffalo 5
Cardiff 5
Dhaka 5
Glasgow 5
Islamabad 5
Johannesburg 5
Kuala Lumpur 5
Kyiv 5
Lahore 5
Lucknow 5
Meppel 5
Mexico City 5
Orem 5
Pune 5
Riyadh 5
Sacramento 5
Santo Stefano di Rogliano 5
Stockholm 5
Ankara 4
Brescia 4
Cape Town 4
Charlotte 4
Dublin 4
Florianópolis 4
Haiphong 4
Istanbul 4
Lima 4
Melbourne 4
Nicosia 4
Paris 4
Phoenix 4
Tanta 4
Toronto 4
Tubarão 4
Acquaviva delle Fonti 3
Ajman 3
Totale 2.275
Salva come PNG Salva come JPEG
Nome #
Pharmacogenetics/Pharmacogenomics of Drug-Metabolizing Enzymes and Transporters 497
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells 145
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 119
miR-22 suppresses DNA ligase III addiction in multiple myeloma 108
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience 101
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review 98
Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysis 82
A 46,XY Female with a 9p24.3p24.1 Deletion and a 8q24.11q24.3 Duplication: A Case Report and Review of the Literature. 82
Raman Spectroscopic Stratification of Multiple Myeloma Patients Based on Exosome Profiling 79
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 78
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics 78
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. (CO-FIRST AUTHOR) 78
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 76
Discovery, Functional Characterization and Therapeutic Targeting of Lnc-17-92 Metabolic Signaling in Multiple Myeloma 75
Identifying prognostic markers for multiple myeloma through integration and analysis of MMRF-CoMMpass data 75
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin 74
Non-coding RNAs in cancer: Platforms and strategies for investigating the genomic "dark matter" 74
DmetTM genotyping: Tools for biomarkers discovery in the era of precision medicine 71
Allometric scaling approaches for predicting human pharmacokinetic of a locked nucleic acid oligonucleotide targeting cancer-associated miR-221 69
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 68
Chromene Derivatives as Selective TERRA G-Quadruplex RNA Binders with Antiproliferative Properties 67
Polymorphic variants in NR1I3 and UGT2B7 predict taxane neurotoxicity and have prognostic relevance in breast cancer patients: a case-control study. 67
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 65
Modeling UGT2B7 and NR1I3 genes through multilayer network to highlight hidden link with taxane neurotoxicity 64
Anti-MALAT1 synthetic oligonucleotides target the proteasome and exert anti-multiple myeloma activity 62
A MIR17HG-derived Long Noncoding RNA Provides an Essential Chromatin Scaffold for Protein Interaction and Myeloma Growth 61
From single level analysis to multi-omics integrative approaches: A powerful strategy towards the precision oncology 61
Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation Perspectives 60
Pharmacogenomics biomarker discovery and validation for translation in clinical practice. 60
ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization 59
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma 58
Mir-22 modulates lenalidomide activity by counteracting myc addiction in multiple myeloma 58
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes 58
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats 57
Genetic variants associated with Fabry disease progression despite enzyme replacement therapy 57
Exploring the impact of lipid droplets on the evolution and progress of hepatocarcinoma 54
The Cytoscan HD Array in the Diagnosis of Neurodevelopmental Disorders 54
GENETIC SUSCEPTIBILITY TO GASTROINTESTINAL SYMPTOMS IN FABRY DISEASE 53
Integration of DNA Microarray with Clinical and Genomic Data 53
Mmrf-commpass data integration and analysis for identifying prognostic markers 52
Mirnas and lncrnas as novel therapeutic targets to improve cancer immunotherapy 52
Ethical Perspectives on Pharmacogenomic Profiling 51
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma 50
The Effect of Physical Activity/Exercise on miRNA Expression and Function in Non-Communicable Diseases-A Systematic Review 49
Genetic variants associated with gastrointestinal symptoms in Fabry disease. 49
DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine 48
From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology 46
null 43
Raman spectroscopic characterization of liver steatosis and fibrosis in a 2D and 3D in vitro thyroxine-treated hypothyroid cellular model 40
Genetic variants associated with Fabry disease progression despite enzyme replacement therapy. (IF 5.168) 40
Advances in Alport syndrome diagnosis using next-generation sequencing 39
Tools in Pharmacogenomics Biomarker Identification for Cancer Patients 37
The potential role of miRNAs in multiple myeloma therapy 35
GPER1 Activation Exerts Anti-Tumor Activity in Multiple Myeloma 31
TERRA G-quadruplex stabilization behind the anti-multiple myeloma activity: Novel insights about resveratrol pleiotropic effects 31
null 31
Functional Role of Linc-RNAs in Multiple Myeloma: Linc-MIR17HG Affects Fatty Acid Biosynthesis Via transcriptional Regulation of ACC1 with Potential Therapeutic Implications 29
Clinical Implementation of Sustainable Functional Foods and Nutraceuticals in Metabolic Health: A Feasibility Study 26
High frequency of COH1 intragenic deletions and duplications detected by MLPA in patients with Cohen syndrome 25
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 14
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92 12
Insulin plant (Costus igneus) extract alleviates steatosis and adiposity in a murine MASLD model by modulating hepatic lipogenesis and the CD9-CFD immunoregulatory axis 6
Totale 4.091
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.748
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.748
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022155 0 0 0 32 8 0 8 29 36 19 17 6
2022/2023453 75 31 22 19 59 40 7 33 60 33 49 25
2023/2024511 91 40 46 35 48 74 28 41 10 17 31 50
2024/2025976 92 33 33 50 62 126 73 60 56 23 156 212
2025/20261.771 130 173 147 191 168 95 250 91 195 168 104 59
2026/2027102 41 61 0 0 0 0 0 0 0 0 0 0
Totale 4.091